baber/WOPTO huggingface dataset:
Patent NZ-302781-A (NZ)
Title: A wireless alerting and telecommunications device for the hearing impaired
Inventor: COSTIGAN PATRICK RYAN
IPC: H04Q7/06
Filed: 1996-02-23
Abstract: A telecommunications system allowing a conventional telecommunications device such as a radio pager, cellular telephone or portable computer equipped with a radio modem (40), to deliver information regarding alarms and events occurring in the environment (12). This is accomplished while still allowing the telecommunication device to operate as originally designed and to support telecommunication with people. The invention was designed primarily for the Deaf and Hearing Impaired but can also be applied in the area of security.
Patent NZ-307524-A (NZ)
Title: Cellulase-containing washing agents
Inventor: MAURER KARL-HEINZ
IPC: C11D3/386
Filed: 1996-04-18
Abstract: PCT No. PCT/EP96/01616 Sec. 371 Date Nov. 21, 1997 Sec. 102(e) Date Nov. 21, 1997 PCT Filed Apr. 18, 1996 PCT Pub. No. WO96/34080 PCT Pub. Date Oct. 31, 1996In washing agents containing tensides and cellulase, the properties of the cellulase which are relevant to the application were to be improved. This was essentially achieved in that use was made of a cellulase mixture in which the first component, with a CMCase activity of 1 U per liter and a protein concentration of a most 3 mg per liter, gives an increase in remission of at least 5 units in the secondary washing test and the second component, with a CMCase activity of 20 U per liter gives an increase in absorption in the cellulose decomposition test of at least 0.075.
Patent NZ-329967-A (NZ)
Title: Adjustment of flow control and roll speed at start of casting of metal strip through rolls
Inventor: BLEJDE WALTER
IPC: B22D11/18
Filed: 1998-03-16
Abstract: Casting metal strip by delivering molten metal to a casting pool (81) supported on a pair of parallel casting rolls (16) and passing metal downwardly between the rolls to produce solidified strip (20). Flow of metal to the casting pool (81) is controlled by an input flow control valve (47). At start of casting when pool (81) is being filled speed of rolls (16) is varied in response to variations between actual instantaneous poo level and predicted level until pool approaches desired operational level. Thereafter any variations between instantaneous roll speed and desired operational roll speed are caused to adjust valve (47) to being pool level and roll speed to desired operational valves. <IMAGE>
Patent NZ-332278-A (NZ)
Title: Process for producing 5-hydroxymethyl substituted oxazolidinone alcohols and transformation to 5 aminomethyl substituted oxazolidinone amines which are useful in production of antibacterial pharmaceuticals
Inventor: PEARLMAN BRUCE A
IPC: C07D263/24
Filed: 1997-03-28
Abstract: A process for producing 5-hydroxymethyl substituted oxazolidinone alcohols (III) from carbamates (IIA) or a trifluoroacetamide (IIB) using a dihydroxy compound (I) as starting material and for the transformation of the hydroxymethyl substituted oxazolidinone alcohols (III) to the corresponding amino compounds, 5-aminomethyl substituted oxazolidinone amines (VII) which are acylated to form commercially useful antibacterial 5-acylamidomethyl substituted oxazolidinone.
Patent NZ-333378-A (NZ)
Title: Diagnosing medical conditions by monitoring peripheral arterial tone and vasoconstriction that relates to cardiopulmonary distress and blood pressure
Inventor: GOOR DANIEL A
IPC: A61B5/022
Filed: 1997-07-23
Abstract: method and apparatus for non-invasive detection of a physiological state or medical condition is disclosed.  The method provides an indication of such state or condition such as myocardial ischemia or sleep apnea, by detecting the peripheral arterial tone's response to such state or condition.  A static pressure field is applied around the distal part of a digit of the subject.  Peripheral arterial tone changes and related volume changes in the distal part of the digit are detected to thereby detect or monitor a physiological state or medical condition.  The apparatus comprises a finger probe (20), in the form of a tube (3) accommodating the patient's finger, which is designed to apply pressure, and a contiguous pressure cuff (40) which extends the boundary of said pressure field.  The finger probe (2) either includes or is associated with a signal sensor/transducer (100, 101).
Patent NZ-335179-A (NZ)
Title: Macropore catalysts containing cobalt, molybdenum and phosphorus for hydro-treating oil feedstocks
Inventor: MIGNARD SAMUEL
IPC: B01J27/18
Filed: 1997-11-07
Abstract: Provided is an alumina based catalyst containing (expressed in weight contents of oxides): 2-10 wt.% of cobalt oxide CoO, 10-30 wt.% of molybdenum oxide MoO3 and 4-10 wt.% of phosphorus oxide P2O5, The catalyst has a BET surface between 100-300 m2/g, an ESH compression set higher than 1.4 MPa, an average pore diameter between 8-11 nm.  The porous volume of pores of diameter greater than 14 nm is less than 0.08 ml/g.  The volume of pores of diameter is less than 8 nm not more than 0.05 ml/g.  The volume of pores of diameter between 8 and 14 nm is between 0.20 ml/g and 0.8 ml/g. The specification also concerns a hydro-treating method using this catalyst, and in particular of hydrodesulphuration.
Patent NZ-337726-A (NZ)
Title: Friction reducing additives for fuels and lubricants particularly iminoacetamides
Inventor: CAREY JAMES THOMAS
IPC: C10L1/228
Filed: 1998-03-31
Abstract: The invention provides certain iminoacetamides which have been prepared by reacting alkylamines with acetoacetamides, and their use as friction reducing additives in fuels and lubes. A lubricant composition comprising a lubricating oil or grease prepared and a friction reducing amount of a reaction product obtained by reacting RXR1NH2 Wherein X=CH2, O, S, or NH; R=hydrocarbyl, alkenyl, or alkyl (C1-C60); and acetoacetamide of the formula CH3COCH2CON(R2)2 wherein R2=H or C1-C4 alkyl.
Patent NZ-500161-A (NZ)
Title: Display billboard and method
Inventor: SCOTT HUNTER TIMOTHY
IPC: G09F1/08
Filed: 1997-10-29
Abstract: A billboard for displaying an image that comprises a three-dimensional structure having at least one panel, which is formed to provide a recess leading toward an apex.  The structure has a display area formed on an inwardly facing surface of the recess, the inwardly facing surface of the recess appearing to protrude instead of recede.  This provides for an image that apparently protrudes from the billboard.
Patent NZ-500713-A (NZ)
Title: 2-aminopropane-1,3-diol compounds and medicinal use thereof
Inventor: ADACHI KUNITOMO
IPC: C07F7/18
Filed: 1998-04-03
Abstract: These compounds, which are useful as preventives or depressants for rejection reactions in organ or bone marrow transplantations and preventives or remedies for various autoimmune diseases, various allergic diseases are represented by general formula (I), pharmaceutically acceptable acid addition salts thereof, or hydrates of the same where  R1, R2, R3 and R4 represent each hydrogen or acyl Also included is 2-amino-2-(2-(4-(1-hydroxy-5-phenylpentyl) phenyl)ethyl)propane-1,3-diol and 2-amino-2-(2-(4-formylphenyl)ethyl)-propane-1,3-diol optionally protected at the amino and/or hydroxy group or salts thereof, which are useful as intermediates in synthesizing the above compounds
Patent NZ-502414-A (NZ)
Title: Use of fatty acid methyl ester ethoxylates as surfactants in agricultural formulations
Inventor: MUENINGHOFF JANE C
IPC: A01N39/04
Filed: 1998-07-13
Abstract: The adjuvant comprises: (a) an ethoxylated fatty acid methyl ester of the formula R1-CO-(CH2CH2O)n-OCH3 where R1 is a C6-C22 alkyl group and n is 1 to about 200; and (b) a component selected from nonionic surfactants, anionic surfactants, cationic surfactants, alkyl esters, phytobland mineral oils, water soluble silicone surfactants, fatty acid dialkyl ethers, fatty acid dialkyl carbonates, vegetable oils, and mixtures thereof.
Patent NZ-509110-A (NZ)
Title: Vapor-permeable waterproof sole for shoes has a vapor-permeable waterproof membrane interposed between upper and lower elements where the lower element has a hollow region that connects to the outside by way of air passages formed in a lower element border
Inventor: POLEGATO MORETTI MARIO
IPC: A43B13/12
Filed: 1999-06-17
Abstract: A vapor-permeable and waterproof sole for shoes, comprising: a lower flat element made of shaped rubber-like material, which has a hollow upper region delimited by a border with air passage openings which extend laterally with respect to the ground resting plane; an upper element; a membrane made of waterproof and vapor-permeable material, which is interposed between said lower and upper elements at said hollow region; said lower and upper elements and said membrane being joined hermetically in the perimetric regions of mutual contact
Patent NZ-510049-A (NZ)
Title: A serine kinase (hsRec2) and its involvement with cyclin E and p53 in the cell cycle
Inventor: HAVRE PAMELA A
IPC: C12Q1/48
Filed: 1999-09-17
Abstract: A method of phosphorylating a serine containing substrate is described.  The method comprises incubating the substrate with ATP and an enzyme that is either hsRec2, muRec2 or a derivative thereof.  The natural substrates of the kinase activity of Rec2 are the cell cycle control proteins such as p53 and cyclin E.  The over expression of Rec2 is known to cause cell-cycle arrest and apoptosis.  It appears these effects are kinase mediated.  Accordingly, a method of assessing antagonists and agonists of Rec2, where the antagonists and agonists have pharmacological activity is described.  Specific binding between hsRec2 and at least three cell cycle control proteins: p53, PCNA and cdc2 are also disclosed.
Patent NZ-513836-A (NZ)
Title: Agents for intravitreal administration to treat or prevent disorders of the eye
Inventor: CASTILLEIOS DAVID
IPC: A61K31/17
Filed: 2000-03-02
Abstract: A therapeutically effective amount of an agent comprising urea or a urea derivative is used in the preparation of a medicament fro delivery into the posterior segment of the eye to treat or prevent disease conditioned in the posterior segment of the eye. Preferably the therapeutic effect is selected from inducing posterior vitreous detachment (PVD) and/or disinsertion of the vitreous body from the retina and epiretinal membranes, causing non-enzymatic dissolution of the hyaloid membrane, causing liquefaction of the vitreous humor, causing diffusion or preventing the accumulation of localized concentrations near the retina of substances that are injurious or pathogenic to the retina, causing dissolution of coagulum within the vitreous humor (as may occur following intravitreal haemorrhage), causing a solvent action on fibroblasts, inhibiting fibroblasts, inhibiting or preventing fibrosis associated with the presence of vitreous heme, inhibiting the proliferation of fibroblasts in ocular tissues, treating, preventing, deterring, stopping or slowing the progression of diabetic retinopathy, treating intravitreal haemorrhage and accelerating the clearance of hemorrhagic blood from the vitreous humor, inducing PVD and/or liquefaction of the vitreous prior to the performance of a vitrectomy thereby limiting the likelihood of retinal detachment, retinal tearing, re-stimulation of retinal haemorrhage or other complications of the vitrectomy procedure, treating vitreous traction associated with macular holes, treating macular degeneration, treat retinitis pigmentosa, prophylaxis to retinal detachment in patients who are at high risk for retinal detachment (e.g. high myopes), treating preretinal and subretinal membranes, treating cystoid macular edema, pre-operative preparation of the eye in the surgical treatment of eye trauma, pre-operative treatment prior to certain types of glaucoma surgery (e. g., those performed for the treatment of neovascular glaucoma), treating occlusion of the central retinal vein or central retinal artery, treating conditions associated with neovascularization such as neovascular iris and neovascular glaucoma, treating ocular ischemic syndrome, treating conditions associated with posterior eye inflammation such as VKH, pars planitis, toxoplasmosis, and improving the delivery and bioavailability to the retina and other tissues of intravitreally administered drugs. A second agent may be included in the medicament selected from non-steroid anti-inflammatory agents, flurburpofen, diclofenac, ketorolac, antimetabolites, mitomicyn C, methotrexate, 6-mecaptopurine, thioguanine, 5-flurorouracil, cytosine arabinoside and 5-azacytidine.
Patent NZ-515657-A (NZ)
Title: Culture medium for the detection of Zygosaccharomyces
Inventor: LEAO CECILIA
IPC: C12N1/16
Filed: 2000-05-31
Abstract: A differential and selective culture medium for Zygosaccharomyces bailii and Zygosaccharomyces bisporus yeasts comprises a base mineral medium supplemented with vitamins and oligoelements required for yeast growth, glucose and formic acid as the only carbon and energy sources and appropriated acid-base indicator having a pKi between 4.5 and 4.8 and optionally and antibiotic inhibitor of bacterial growth and agar. Also described is a process for the detection of Zygosaccharomyces bailii and Zygosaccharomyces bisporus yeast comprising using the differential and selective culture medium.
Patent NZ-516068-A (NZ)
Title: Process for making alcohols by hydrogenation of aldehydes in liquid phase in the presence of water using nickel and at least one other transition metal
Inventor: KNOOP CORD
IPC: C07C29/14
Filed: 2001-12-11
Abstract: A process for the hydrogenation of reaction mixtures from the hydroformylation olefins having from 4-16 carbon atoms in the homogenous liquid phase over fixed-bed catalysts comprising at least one element of transition group eight of the Periodic Table of Elements, wherein the homogenous liquid phase of the output from the reactor still contains from 0.05 to 10% by weight of water.
Patent NZ-518616-A (NZ)
Title: Stackable container made from multiple blanks (a main blank and a pair of end wall blanks)
Inventor: BLOMFIELD GREGORY THOMAS
IPC: B65D21/032
Filed: 2002-04-26
Abstract: A container formed from multiple blanks is disclosed, the container being substantially of a rectanguloid form defined by a base, sidewalls, end walls and lid flaps from the sidewalls wherein the base, sidewalls, and lid flaps are formed at least in part from the same blank and each end wall is defined in part only by the main blank component, wherein there is associated with the main blank component, at each end, an end wall defining blank and wherein each end wall blank is fixed externally of the main blank so as to provide an exposed panel surface to at least substantially the full height of the container and to provide a hinged flange externally affixed to each side wall.
Patent NZ-521769-A (NZ)
Title: The high bone mass gene of 11q13.3
Inventor: CARULLI JOHN P
IPC: A61K38/00
Filed: 2000-06-21
Abstract: Methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants. What is disclosed relates to the high bone mass gene, the corresponding wild-type gene, and mutants. The genes disclosed are implicated in bone development and in focal adhesion signaling. Also disclosed are nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, methods for treating, diagnosing and preventing osteoporosis is disclosed.
Patent NZ-522385-A (NZ)
Title: A process for the preparation of 4-(4-pyridinyl)benzoic acid and salts theeof
Inventor: PERVEZ MOHAMMED
IPC: C07B61/00
Filed: 2001-05-22
Abstract: A process for the preparation of 4- (4-pyridinyl) benzoic acid, or a salt thereof, comprising: reacting a mixture of 4-carboxybenzeneboronic acid, optionally in the form of a salt, 4-bromopyridine, also optionally in the form of a salt, and a base, all parts being substantially dissolved in a solvent, in the presence of a catalyst of formula R3P)4Pd, wherein R is selected from an aromatic ring, a heteroaromatic ring, a cycloalkyl group or an aliphatic group, the catalyst may be water soluble such as palladium acetate or tetrakis(triphenylphosphine)palladium(0) is disclosed.
Patent NZ-527944-A (NZ)
Title: Process for the preparation of middle distillates
Inventor: HOEK AREND
IPC: C10G65/04
Filed: 2002-03-01
Abstract: A process for the preparation of one or more hydrocarbon fuel products boiling in the kerosene/diesel range from a stream of hydrocarbons produced in a Fischer-Tropsch process is disclosed, wherein synthesis gas is converted into liquid hydrocarbons, at least a part of the hydrocarbons boiling above the kerosene/diesel range, comprising the following steps: (1) hydrocracking/hydroisomerising at least a part of the Fischer-Tropsch hydrocarbons stream at a conversion per pass of at most 80 wt% of the material boiling above 370 degree C into material boiling below 370 degree C, (2) separating the product stream obtained in step (1) into one or more light fractions boiling below the kerosene/diesel boiling range, one or more fractions boiling in the kerosene/diesel boiling range and a heavy fraction boiling above the kerosene/diesel boiling range, (3) hydrocracking/hydroisomerising the major part of the heavy fraction obtained in step (2) at a conversion per pass of at most 80 wt% of the material boiling above 370 degree C into material boiling below 370 degree C, (4) separating the product stream obtained in step (3) into one or more light fractions boiling below the kerosene/diesel boiling range, one or more fractions boiling in the kerosene/diesel boiling range and a heavy fraction boiling above the kerosene/diesel boiling range, (5) hydrocracking/hydroisomerising the major part of the heavy fraction obtained in step (4) in the hydrocracking/hydroisomerising process described in step (1) and/or step (3), in which process the Fischer-Tropsch hydrocarbons stream comprises at least 35 wt% C30+ (based on total amount of hydrocarbons in the Fischer-Tropsch hydrocarbons stream) and in which stream the weight ratio C60+/C30+ is at least 0.2.
Patent NZ-528580-A (NZ)
Title: Fusion proteins
Inventor: MCKERRACHER LISA
IPC: A61K47/48
Filed: 2002-04-08
Abstract: The Rho family GTPases regulates axon growth and regeneration. Inactivation of Rho with C3, a toxin from Clostridium botulinum , can stimulate regeneration and sprouting of injured axons. The present invention provides novel chimeric C3-like Rho antagonists. These new antagonists are a significant improvement over C3 compounds because they are 3-4 orders of magnitude more potent to stimulate axon growth on inhibitory substrates than recombinant C3. The invention further provides evidence that these compounds promote repair when applied to the injured mammalian central nervous system.
Patent NZ-532500-A (NZ)
Title: Method for producing an impact-resistant polymethylmethacrylate, and corresponding polymethylmethacrylate (PMMA)
Inventor: KABS KLAUS
IPC: C08J3/22
Filed: 2003-01-15
Abstract: A plastic moulding made from an impact-resistant polymer based on polymethyl methacrylate (PMMA) is disclosed, wherein the plastic moulding is obtained by polymerizing a mixture made from: 65-99.5% by weight of methyl methacrylate; 0-3% by weight of an unsaturated carboxylic acid; 0.5-35% by weight of an impact modifier; 0-1% by weight of a crosslinker; 0.5-1% by weight of a stabilizer; 0.001-0.1% by weight of an initiator; 0.01-1.0% by weight of a release agent; and 0.001-0.031% by weight of a regulator.
Patent NZ-534730-A (NZ)
Title: Heterocyclic tripeptides as hepatitis C inhibitors
Inventor: LLINAS-BRUNET MONTSE
IPC: A61P31/14
Filed: 2003-01-24
Abstract: A compound of formula (I) wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O-(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O-(C1-6)alkyl, amido, amino or phenyl; R2 is t-butyl, -CH2-C(CH3)3, or -CH2-cyclopentyl; R3 is t-butyl or cyclohexyl and R4 is cyclobutyl, cyclopentyl, or cyclohexyl; or a pharmaceutically acceptable salt thereof.
Patent NZ-539119-A (NZ)
Title: Lupin proteins, a process for the manufacture thereof and compositions containing finely divided fat soluble actives and/or colourants in a matrix based on the lupin proteins
Inventor: FUNDA ELGER
IPC: A23L33/155
Filed: 2003-10-02
Abstract: Disclosed is a process for the manufacture of a modified lupin protein, which comprises adjusting an aqueous solution or suspension of lupin proteins of native origin having a dry mass content of from 0.1 to 20 % to pH 3 to 9, adding 0.01 to 10 % by weight of a protease, in relation to the dry weight of the lupin protein, incubating the protein solution or suspension at a temperature of from 5 to 70 DEG C until a degree of hydrolysis of from 1 to 30 % is obtained, and inactivating the protease, to modified lupin proteins obtained by this process, to compositions containing said lupin proteins together with a fat-soluble active ingredient or colorant, and to the use of said composition for enrichment, fortification and/or coloration of food, beverages, animal feeds, cosmetics or drugs. Further, disclosed are food, beverage, animal feeds, cosmetics or drugs containing said composition.
Patent NZ-539768-A (NZ)
Title: A syntactic phenolic foam composition
Inventor: ORPIN MURRAY
IPC: C08J9/32
Filed: 2003-11-18
Abstract: Disclosed is a highly reactive phenolic resole resin, the resin being obtained by reacting a substituted or unsubstituted phenol and an aldehyde in the presence of an alkaline catalyst at a temperature of no more than 65°C and then neutralizing to a pH of 5.5 - 6.6. Also disclosed is a pre-mix for a syntactic phenolic foam composition, the premix comprising: 1) thermally expandable and/or expanded thermoplastic microspheres, the microspheres comprising a thermoplastic polymer shell made of a homopolymer or copolymer of 100 to 25, for example 93 to 40, parts by weight of a nitrile-containing, ethylenically unsaturated monomer, or a mixture thereof; and 0 to 75, for example 7 to 60, parts by weight of a non-nitrile-containing, ethylenically unsaturated monomer, or a mixture thereof; and a propellant, or a mixture thereof, trapped within the thermoplastic polymer shell; and one of either 2) a highly reactive phenolic resole resin, the resin being obtainable by reacting a substituted or unsubstituted phenol and an aldehyde in the presence of an alkaline catalyst at a temperature of no more than 65°C and then neutralizing to a pH of 5.5 - 6.6; or 3) an acidic catalyst for curing the phenolic resole resin. Also disclosed is a syntactic phenolic foam composition, comprising all of the components 1), 2) and 3) above.
Patent NZ-544661-A (NZ)
Title: Strength-enhanced, lightweight lignocellulosic composite board materials and methods for their manufacture
Inventor: LIU FEIPENG
IPC: B32B21/00
Filed: 2004-04-20
Abstract: Lightweight lignocellulosic board materials, such as oriented strand board and others, having reduced densities while maintaining suitable mechanical properties, and methods for their manufacture.
Patent NZ-548569-A (NZ)
Title: Shearing apparatus
Inventor: HYLAND RAYMOND
Filed: 2006-07-18
Abstract: A shearing apparatus (40) supports an animal to be shorn. The apparatus includes a first support means (41) and a second support means (42), and is moveable between a first configuration in which the first support means supports the animal and a second configuration in which the second support means supports the animal. The second support means can be lowered from above onto an animal supported in the first configuration, movement from the first configuration to the second configuration including inversion of the second support means. The apparatus may support the animal at a height such that a shearer can maintain a substantially upright posture while shearing.